S&P 500 slips after report on coronavirus drug trial

All three main U.S. stock indexes fell back from gains of over 1% after the Financial Times reported that a Chinese trial showed that Gilead Science's remdesivir did not improve patients' condition or reduce the pathogen's presence in the bloodstream.

from Stocks-Markets-Economic Times https://ift.tt/2S58NT4
via Latest News of India